We have not reviewed the charts of Acadia Pharmaceuticals (ACAD) since Aug. 9, 2017. Way back then we wrote that "ACAD looks strong enough for a rally to the upper $30s but a close above $40 will be more impressive. Trade ACAD from the long side with a reasonable stop. A breakout above $40 could mean a longer-term rally into the $50s."
Prices eventually reached the $50's but 2018 saw a hard decline to new lows. Now the picture is much, much different.